University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 1B-09-1


 
Description: A Phase II, Multi-Center, Randomized, Open-Label Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Patients With Advanced Breast Cancer.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Agustin GarciaM.D.

Data Management
NameTitle
Joanne SakamotoR.N.
Gamaliel JacintoD.M.
Yvonne FloresD.M.
Jessica LevanoR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.